Arceci RJ - Search Results

1

Beverley PC, Egeler RM, Arceci RJ, Pritchard J. Beverley PC, et al. Among authors: arceci rj. Nat Rev Cancer. 2005 Jun;5(6):488-94. doi: 10.1038/nrc1632. Nat Rev Cancer. 2005. PMID: 15928676

2

Summary of the 12th Nikolas Symposium dendritic cell differentiation: signals, signaling and functional consequences as clues to possible therapy.

Nichols KE, Egeler RM, Perry VH, Arceci R. Nichols KE, et al. J Pediatr Hematol Oncol. 2003 Mar;25(3):193-7. doi: 10.1097/00043426-200303000-00003. J Pediatr Hematol Oncol. 2003. PMID: 12621236 No abstract available.

3

Biology of Langerhans cells and Langerhans cell histiocytosis.

Bechan GI, Egeler RM, Arceci RJ. Bechan GI, et al. Among authors: arceci rj. Int Rev Cytol. 2006;254:1-43. doi: 10.1016/S0074-7696(06)54001-X. Int Rev Cytol. 2006. PMID: 17147996 Review.

4

Controversies and new approaches to treatment of Langerhans cell histiocytosis.

Arceci RJ, Brenner MK, Pritchard J. Arceci RJ, et al. Hematol Oncol Clin North Am. 1998 Apr;12(2):339-57. doi: 10.1016/s0889-8588(05)70514-1. Hematol Oncol Clin North Am. 1998. PMID: 9561904 Review.

5

Analysis of outcome for patients with mass lesions of the central nervous system due to Langerhans cell histiocytosis treated with 2-chlorodeoxyadenosine.

Dhall G, Finlay JL, Dunkel IJ, Ettinger LJ, Kellie SJ, Allen JC, Egeler RM, Arceci RJ. Dhall G, et al. Among authors: arceci rj. Pediatr Blood Cancer. 2008 Jan;50(1):72-9. doi: 10.1002/pbc.21225. Pediatr Blood Cancer. 2008. PMID: 17455311

6

Langerhans cell histiocytosis is a neoplasm and consequently its recurrence is a relapse: In memory of Bob Arceci.

Egeler RM, Katewa S, Leenen PJ, Beverley P, Collin M, Ginhoux F, Arceci RJ, Rollins BJ; Steering Committee of the Nikolas Symposium. Egeler RM, et al. Among authors: arceci rj. Pediatr Blood Cancer. 2016 Oct;63(10):1704-12. doi: 10.1002/pbc.26104. Epub 2016 Jun 17. Pediatr Blood Cancer. 2016. PMID: 27314817 Review.

7

Familial clustering of Langerhans cell histiocytosis.

Aricò M, Nichols K, Whitlock JA, Arceci R, Haupt R, Mittler U, Kühne T, Lombardi A, Ishii E, Egeler RM, Danesino C. Aricò M, et al. Br J Haematol. 1999 Dec;107(4):883-8. doi: 10.1046/j.1365-2141.1999.01777.x. Br J Haematol. 1999. PMID: 10606898 Free article.

8

2'-Chlorodeoxyadenosine (2-CdA) as salvage therapy for Langerhans cell histiocytosis (LCH). results of the LCH-S-98 protocol of the Histiocyte Society.

Weitzman S, Braier J, Donadieu J, Egeler RM, Grois N, Ladisch S, Pötschger U, Webb D, Whitlock J, Arceci RJ. Weitzman S, et al. Among authors: arceci rj. Pediatr Blood Cancer. 2009 Dec 15;53(7):1271-6. doi: 10.1002/pbc.22229. Pediatr Blood Cancer. 2009. PMID: 19731321 Clinical Trial.

9

Clonal relationship between precursor T-lymphoblastic leukaemia/lymphoma and Langerhans-cell histiocytosis.

Feldman AL, Berthold F, Arceci RJ, Abramowsky C, Shehata BM, Mann KP, Lauer SJ, Pritchard J, Raffeld M, Jaffe ES. Feldman AL, et al. Among authors: arceci rj. Lancet Oncol. 2005 Jun;6(6):435-7. doi: 10.1016/S1470-2045(05)70211-4. Lancet Oncol. 2005. PMID: 15925822 No abstract available.

10

Phage display generation of a novel human anti-CD1A monoclonal antibody with potent cytolytic activity.

Bechan GI, Lee DW, Zajonc DM, Heckel D, Xian R, Throsby M, van Meijer M, Germeraad WT, Kruisbeek AM, Egeler RM, Arceci RJ. Bechan GI, et al. Among authors: arceci rj. Br J Haematol. 2012 Nov;159(3):299-310. doi: 10.1111/bjh.12033. Epub 2012 Aug 30. Br J Haematol. 2012. PMID: 22934889 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

206 results

Search Page